Carcinoma, Squamous Cell D002294

Diseases [C] » Neoplasms [C04] » Neoplasms by Histologic Type » Neoplasms, Glandular and Epithelial » Carcinoma » Carcinoma, Squamous Cell

Diseases [C] » Neoplasms [C04] » Neoplasms by Histologic Type » Neoplasms, Glandular and Epithelial » Neoplasms, Squamous Cell » Carcinoma, Squamous Cell

Description

A carcinoma derived from stratified SQUAMOUS EPITHELIAL CELLS. It may also occur in sites where glandular or columnar epithelium is normally present. (From Stedman, 25th ed)   MeSH

Hierarchy View

Subtype Terms (3)

Bowen's Disease
8 drugs (6 approved, 2 experimental)

Esophageal Squamous Cell Carcinoma
72 drugs (26 approved, 46 experimental)

Squamous Cell Carcinoma of Head and Neck
519 drugs (155 approved, 364 experimental)


Phase 2 Indicated Drugs (130)


Organization Involved with Phase 3 Indications (143)

Organization Involved with Phase 2 Indications (324)

Acceleron Pharma, Inc.

Acerta Pharma

Advaxis, Inc.

Alberta Cancer Foundation

All India Institute of Medical Sciences

Alphamab Co., Ltd.

Altor Bioscience

ALX Oncology

Amarex Clinical Research

Anhui College of Traditional Chinese Medicine

Anhui Medical University

AperiSys, Inc

Apices Soluciones S.L.

Arizona State University

ArQule

Astellas

Australasian Gastro-Intestinal Trials Group

Aventis

Axelar AB

Badalona Hospital Germans Trias i Pujol

Bayer

Baylor University

Beijing Konruns Pharmaceutical Co., Ltd.

Benitec Ltd

Berg, LLC

BGI Group

Bhagwan Mahaveer Jain Hospital

Bharat Hospital

BIND Therapeutics

Biolitec Pharma Ltd.

Biontech

Biothera

Brown University

BTG

Canadian Cancer Trials Group

Canadian Institutes of Health Research (CIHR)

Cascadian Therapeutics Inc.

Case Western Reserve University

Cedars-Sinai Medical Center

Celgene

Celldex Therapeutics

Center for Clinical and Cosmetic Research

Central India Cancer Research Institute, Nagpur

Centre Hospitalier of Chartres

Centro Oncológico de Galicia

Checkmate Pharmaceuticals

China Three Gorges University, Yichang, China

Chinese Society of Lung Cancer

Christian Medical College, Vellore, India

CHU Mont-Godinne

Chung Shan Medical University

CISSS de Chaudière-Appalaches

City of Hope National Medical Center

Clinuvel Pharmaceuticals Limited

Cornell University

Covance

CSM Medical University, Lucknow

CTI BioPharma

Curie Institute

Curie Manavata Cancer Center, Nashik, India

Daiichi Sankyo

Dartmouth University

Deenanath Mangeshkar Hospital & Research Centre

Department of Radiation Oncology

Dong-A University

Doublle Bioproduct Inc

Duke University

Dynavax Technologies Corporation

Eastern Cooperative Oncology Group

Eisai

Eli Lilly

Elisabeth-TweeSteden Ziekenhuis

Emory University

Epizyme, Inc.

Erasmus University Rotterdam

Exelixis

Exicure, Inc.

Federation Francophone de Cancerologie Digestive

First People's Hospital of Hangzhou

Fondation ARC

Fondazione Giovanni Pascale

Fondazione Melanoma Onlus

Fundação de Amparo à Pesquisa do Estado de São Paulo

Georgetown University

German Cancer Research Center

GKNM Hospital, Coimbatore, India

Gliknik Inc.

Glycotope GmbH

Government Medical College, Aurangabad, India

Groupe Cooperateur Multidisciplinaire en Oncologie (GERCOR)

GROUPE ONCOLOGIE RADIOTHERAPIE TETE ET COU

Grupo Español de Tratamiento de Tumores de Cabeza y Cuello

Grupo Espanol Multidisciplinario del Cancer Digestivo

Gruppo Oncologico del Nord-Ovest

Guangzhou Medical University

Guizhou Medical University

Gynecologic Oncology Group

Gynecologic Oncology of Indiana

Hannover Medical School

Harvard University

HealthCare Global Enterprise Ltd.

Hebrew University

Hellenic Cooperative Oncology Group

Hengrui Therapeutics, Inc.

Hookipa Biotech

Hoosier Cancer Research Network

Hospital de Manises

Hospital de Mataró

Hospital Infanta Sofia

Hospital Son Llatzer

Hospital Virgen Blanca (León)

Humboldt University

Icahn School of Medicine at Mount Sinai

ICO Hospital Durans i Reynals

IKF Klinische Krebsforschung GmbH am Krankenhaus Nordwest

Imclone

Immunicum AB

Immunovative Therapies

Indena S.p.A

Indiana University

Inovio Pharmaceuticals

Institut Gustave Roussy

Instituto do Cancer do Estado de São Paulo

International Rare Cancers Initiative (IRCI ) This study is indorsed by IRCI

Iovance

IQVIA

IRX Therapeutics

ISA Pharmaceuticals

Istituto Oncologico Veneto

Istituto Oncologico Veneto IRCCS

James and Esther King Biomedical Research Program

Jaslok Hospital and Research Centre, Mumbai, India

Johns Hopkins University

Joseph Sanchez Foundation

J. W. Goethe University

Kadoorie Foundation

Kaohsiung Medical University

Karyopharm Therapeutics Inc

Katholieke Universiteit Leuven

Korean South West Oncology Group

Kura Oncology, Inc.

Laboratorio Elea S.A.C.I.F. y A.

Leiden University

Lithuanian University of Health Sciences

Louisiana State University

Loyola University

Mahidol University

Mayo Clinic

McGill University

Medical Center Haaglanden

Medical Center Leeuwarden

Medical College of Wisconsin

MedImmune

Medisch Spectrum Twente

MedSIR

Meenakshi Ammal Dental College and Hospital

Memorial Hermann Health System

Memorial Sloan-Kettering Cancer Center

Merck Serono

Moorgreen Hospital, Southampton

Nanchang University

Nang Kuang Pharmaceutical Co., Ltd.

Nanjing University

Nanobiotix

NanoCarrier Co., Ltd.

NantCell, Inc.

Nantong University

NantWorks

National Baromedical Services

National Cancer Center, Korea

National Cancer Institute, France

National Comprehensive Cancer Network

National Institute of Dental and Craniofacial Research (NIDCR)

National Institutes of Health (NIH)

National University of Singapore

Natural Life Nutrition Inc.

Netherlands Cancer Institute

New Mexico Cancer Care Alliance

New York University

NextCure, Inc.

Ningxia Medical University

NKMAX Co., Ltd.

Nooshin Hashemi-Sadraei

Novartis

NOW Foods

Ocellaris Pharma, Inc.

Ohio State University

Oncolys BioPharma Inc

Onconova Therapeutics, Inc.

OncoSec Medical Incorporated

Oncovir, Inc.

Oregon Health and Science University

OSI Pharmaceuticals

Paracelsus Medical University

PCI Biotech AS

PDS Biotechnology Corp.

Pennsylvania State University

Peplin

PharmaBio Development Inc.

Pharmaceutical Research Associates, Inc. (PRA)

Pharmacyclics

PhytoHealth Corporation

Piramal

PPD

PrECOG, LLC.

Prince of Songkla University

Prisma Health

Privo Technologies

Rakuten

Regional Cancer Centre, Trivandram

Replimune Inc.

RTOG Foundation

Russian Academy of Medical Sciences

Rutgers University

Samyang Biopharmaceuticals Corporation

Sanford Health

Seattle Genetics

Sensei Pharmaceuticals, Inc.

Seoul National University

Shantou University

Shire

Sichuan University

SignalRX Pharmaceuticals, Inc.

Sirnaomics

Soonchunhyang University

Southderm Pty Ltd

Southern Illinois University

Southern Medical University

Southwest Medical University

Southwest Oncology Group

Spanish Oncology Genito-Urinary Group

Stanford University

State University of New York

State University of New York, Buffalo

State University of New York, Syracuse

Sungkyunkwan University

Sunshine Lake Pharma Co., Ltd.

Symphogen A/S

SynCore Biotechnology

Taipei Veteran General hospital

Takeda

Tarveda Therapeutics

Tata Memorial Hospital

Tel Aviv University

Temple University

The Cleveland Clinic

The First People's Hospital of Hangzhou

The Jewish General Hospital, Montreal QC, Canada

The Kidney Foundation of Canada

The University of Texas, Dallas

Thomas Jefferson University

Threshold Pharmaceuticals

Transgene

Trial Form Support S.L.

Trium Analysis Online GmbH

Tsinghua University

UNICANCER

United States Air Force

Universidad Autonoma de Barcelona

Universidad Autonoma de Madrid

Universidad Complutense de Madrid

University of Amsterdam

University of Arizona

University of Attiko

University of Barcelona

University of Calgary

University of California, Los Angeles

University of California, San Diego

University of California, San Francisco

University of Campinas

University of Chicago

University of Cincinnati

University of Duesseldorf

University of Erlangen-Nuremberg

University of Franche-Comté

University of Heidelberg

University of Kansas

University of Kentucky

University of Lausanne

University of Liverpool

University of London

University of Maryland

University of Miami

University of Michigan

University of Milan

University of Missouri

University of Montreal

University of Nantes

University of Nebraska

University of New Mexico

University of Nice Sophia Antipolis

University of North Carolina at Chapel Hill

University of Paris

University of Pittsburgh

University of Rochester

University of Salamanca

University of Salzburg

University of Sao Paulo

University of South Carolina

University of Southern California

University of South Florida

University of Tennessee

University of Texas at Houston

University of Texas, San Antonio

University of Toronto

University of Toulouse

University of Tuebingen

University of Virginia

University of Washington

University of Wisconsin

University of Zaragoza

Uppsala University

Vanderbilt University

VentiRx Pharmaceuticals Inc.

Verastem, Inc.

V Foundation

Vlaams Instituut voor Biotechnologie (VIB)

Wake Forest University

Washington University in St. Louis

Wayne State University

Wenzhou Medical University

Yale University

Yeshiva University

Yonsei University

Organization Involved with Phase 1 Indications (76)

Hierarchy Tree View

UMLS Data


YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.